Navigation Links
BioLife Solutions CEO Issues 2010 Corporate Update
Date:1/10/2011

ge of development.
  • 2010 revenue from this segment grew 34% from 2009, and accounted for about 31% of total 2010 revenue.  
  • Many regenerative medicine customers have the potential to generate in excess of $1 million of annual revenue for BioLife if regulatory approvals are obtained and the products are successfully commercialized.

  • Contract Manufacturing Services – A New Business and Revenue Stream

  • Preliminary contract manufacturing revenue for 2010 was about 10% of total revenue. This was a new customer type for the Company in 2010 as we began offering additional services that leverage our expertise and the capacity created by our investment in internal manufacturing.
  • In the fourth quarter we secured a long-term contract manufacturing relationship with a leading life sciences tools company, in which we will manufacture a private labeled cord blood stem cell freeze media product for our partner.  We estimate our partner has approximately 10% of the market for cord blood stem cell freeze media products.
  • We estimate that nearly all 2010 contract-manufactured products are intended for distribution to cord blood banks in the biobanking segment, and we expect continued growth in this segment in 2011.

  • Distributor Sales – Growth in Our Indirect Sales Channel

  • Revenue from our indirect distribution channel doubled from 2009 as our partners increased their order volume significantly in the fourth quarter and full year 2010.  Revenue from this channel was about 10% of total revenue.

  • In summary, 2010 was pivotal year in the Company's history and growth as we continued to build a recurring revenue base that can transform BioLife into a valuable enterprise and an attractive investment opportunity.  We remain focused on our financial priorities for the next 24 to 36 months, which include achieving positive cash flow and reducing our debt levels.  In
    '/>"/>

    SOURCE BioLife Solutions, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3

    Related biology technology :

    1. BioLife Solutions Credit Facility Increased to $9 Million
    2. BioLife Solutions HypoThermosol(R) Adopted by MicroIslet for Processing Pancreatic Islet Cells to Treat Diabetes
    3. BioLife Solutions Submits FDA Master File on HypoThermosol(R) Preservation and Storage Media for Cells, Tissues
    4. BioLife Solutions Granted European Biopreservation Patent
    5. BioLife Solutions Completes Safety Studies on HypoThermosol(R) and CryoStor(TM)
    6. BioLife Solutions Joins Prestigious Biomedical Excellence for Safer Transfusion Collaborative
    7. BioLife Solutions Launches BioPreservation Today(R) Industry Newsletter
    8. Improved Cryopreservation Outcomes in Potential $100B Tissue Engineering Market Enabled by BioLife Solutions CryoStor(TM)
    9. Rutgers University Cell and DNA Repository Adopts BioLife Solutions CryoStor(TM) as Standard Biopreservation Media
    10. BioLife Solutions Announces Validation and Start-Up of New Internal Manufacturing Facility for Serum-Free Cell and Tissue Biopreservation Media Products
    11. BioLife Solutions and STEMCELL Technologies Announce Worldwide Distribution Agreement
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:1/15/2014)... Pittsburgh, PA (PRWEB) January 15, 2014 The ... Company, publisher of Food Safety Tech , an e-Journal ... has signed an agreement for the second year for the ... with Pittcon 2014. The partnership provides that the registration fee ...
    (Date:1/15/2014)... Cynvenio, a cancer diagnostics company focused on ... of tumor cells in the bloodstream, today announced that ... support application powered by CollabRx, Inc. , Available ... Therapy Finder will provide breast cancer patients and their ...
    (Date:1/15/2014)... 2014 This webinar will focus on ... safety assessment in biosimilars. , Regulatory frameworks are evolving ... development, however the complex nature of biopharmaceuticals makes the ... efficacy extremely challenging. Based on the specific aspects of ...
    (Date:1/15/2014)... Reston, VA (PRWEB) January 15, 2014 ... education have continued their sponsorship of an annual competition ... interest in, and access to, innovative STEM study. The ... , TEAMS: Tests of Engineering Aptitude, Mathematics, and ...
    Breaking Biology Technology:Pittcon Announces Second Year Partnership With Food Safety Tech 2Pittcon Announces Second Year Partnership With Food Safety Tech 3Cynvenio Offers New Breast Cancer Therapy Finder Application for its ClearID Breast Cancer Genomic Test 2Cynvenio Offers New Breast Cancer Therapy Finder Application for its ClearID Breast Cancer Genomic Test 3Xtalks Life Sciences Webinar Examines Safety Assessment of Biosimilars 2Technology Student Association Partners with Leaders in STEM Education Advocacy for Annual Competition 2Technology Student Association Partners with Leaders in STEM Education Advocacy for Annual Competition 3Technology Student Association Partners with Leaders in STEM Education Advocacy for Annual Competition 4Technology Student Association Partners with Leaders in STEM Education Advocacy for Annual Competition 5
    ... , , , ... MITI ) ("Micromet" or the "Company"), a biopharmaceutical company ... inflammation and autoimmune diseases, today announced the closing of ... common stock. Micromet also announced that the underwriters ...
    ... SHANGHAI, Aug. 4 /PRNewswire-Asia/ -- ... ShangPharma Corporation, announced,today that it has moved its drug ... ChemPartner will provide fully integrated,services in the areas of ... Members of the joint project team from both sides ...
    ... Nile Therapeutics, Inc. (Nasdaq: NLTX ), a company ... today announced dosing of its first patient in a Phase 2 ... acute heart failure. , , The single-blind, placebo-controlled ... safety and tolerability of CD-NP when infused for up to 72 ...
    Cached Biology Technology:Micromet Closes $80.5 Million Public Offering of Common Stock 2Micromet Closes $80.5 Million Public Offering of Common Stock 3Micromet Closes $80.5 Million Public Offering of Common Stock 4Shanghai ChemPartner and ELARA Pharmaceuticals Expand Drug Discovery Collaboration to a New Level 2Nile Therapeutics, Inc. Announces Dosing of First Patient in Phase 2 Study of CD-NP for the Treatment of Acute Heart Failure 2Nile Therapeutics, Inc. Announces Dosing of First Patient in Phase 2 Study of CD-NP for the Treatment of Acute Heart Failure 3
    (Date:4/17/2014)... new early-warning signs of the potential loss of sight ... for the diagnosis and treatment of diabetic retinopathy, potentially ... "We had not expected to see such striking changes ... Elsner, professor and associate dean in the IU School ... set out to study the early signs, in volunteer ...
    (Date:4/17/2014)... University of Texas Medical Branch at Galveston are ... with radiation for cervical cancer should begin colorectal ... The UTMB researchers, finding a high incidence of ... with radiation, offer new recommendations that the younger ... about eight years after their initial cervical cancer ...
    (Date:4/17/2014)... way the immune system may fight cancers and viral ... cells to treat illness. , The research, in mice, ... "neighborhood police" specialized squads of defenders that patrol ... entire city, the body. , Scientists at Washington University ... the liver, skin and uterus each has dedicated immune ...
    Breaking Biology News(10 mins):New technique detects microscopic diabetes-related eye damage 2New technique detects microscopic diabetes-related eye damage 3Radiation therapy for cervical cancer increases risk for colorectal cancer 2Some immune cells defend only 1 organ 2
    ... are invading the Great Lakes and changing the ecology of ... the March issue of the Journal of Great Lakes Research ... species, their ability to wrest territory from native fish plays ... , In the study, McMaster's Sigal Balshine, an assistant professor ...
    ... University's Pratt School of Engineering have created a new ... the probe creates a picture of the whole heart ... to image a single heart cross section. , The ... the condition of the heart, but also for use ...
    ... the brain and, more specifically, how nerve cells form billions of ... a scientific mystery. , A team headed by Drs. Robin Hiesinger ... have unraveled a piece of that puzzle by finding a gene ... their work appears today in the journal Neuron. , "We were ...
    Cached Biology News:Duke engineers develop new 3-D cardiac imaging probe 2
    Screening test for the detection of Salmonella sp. by means of DNA amplification, subsequent molecular hybridization and detection on a microtitre plate....
    ... General description: The "egg crate" style ... any Costar flat bottom strips. Linkage: This ... created to easily match Cornings product number. ... under the old Sigma-Aldrich number (Z71,456-9) or ...
    ... This reagent is intended for use as ... MTF). Michels Transport Fluid is useful for ... lymph nodes) for immunofluorescence studies. Samples may ... days at room temperature. Michels Transport Fluid ...
    ... Two sizes available for use with 96- or 384-well ... 96 for ease of location on 96-tube plates ... the skirt of the plate* Efficient sealing is ... in conjunction with screw or clip-down hot lid thermal ...
    Biology Products: